ADC,	antibody–drug conjugates
Akt,	serine-threonine protein kinase B
APC,	antibody–photoabsorber conjugate
BCL,	B cell lymphoma BCL2
BiTE,	bi-specific T cell engager
B-RAF,	B-Raf proto-oncogene, serine/threonine kinase
BV,	brentuximab vedotin
B2M,	beta 2 microglobulin
CBCL,	cutaneous B cell lymphoma
CCR,	C-C chemokine receptor
CD,	cluster of differentiation
csHSP70,	cell surface heat shock protein 70
CTCL,	cutaneous T cell lymphoma
CTLA4,	cytotoxic T-lymphocyte-associated protein 4
CXCL,	chemokine (C-X-C motif) ligand
CXCR,	C-X-C chemokine receptor
DLBCL,	diffuse large B cell lymphoma
EBV,	Epstein–Barr virus
EMA,	European Medicine Agency
FDA,	Food and Drug Administration
FCL,	follicle center lymphoma
FISH,	fluorescence in situ hybridization
GNA13,	guanine nucleotide-binding protein subunit alpha-13
GPCR,	G protein coupled receptor
HLA,	human leukocyte antigen
HTLV-1,	human T cell leukemia virus 1
ICOS,	inducible T cell costimulator
IL,	interleukin
IR700,	IRdye 700DX®
JAK,	Janus kinase
LPD,	lymphoproliferative disorders
LyP,	lymphomatoid papulosis
mAb,	monoclonal antibody
MAPK,	mitogen-activated protein kinase
MAPK3,	mitogen-activated protein kinase 3 or extracellular signal-regulated kinase 1 (ERK1)
MDR1,	multidrug resistance-1
MF,	mycosis fungoides and its variants—folliculotropic MF, pagetoid reticulosis, granulomatous slack skin
MMAE,	monomethyl auristatin E
mTOR,	mammalian target of rapamycin
MYC,	Myc proto-oncogene, bHLH transcription factor
NF-kB,	nuclear factor kappa-light-chain-enhancer of activated B cells
NK,	natural killer
NHL,	non-Hodgkin’s lymphoma
NIR-PIT,	near-infrared photoimmunotherapy
PCALCL,	primary cutaneous anaplastic large cell lymphoma
PCDLBCL, LT,	primary cutaneous diffuse large B cell lymphoma, leg type
PCFCL,	primary cutaneous follicle center lymphoma
PCMZL,	primary cutaneous marginal zone lymphoma
PCR,	polymerase chain reaction
PD-1,	programmed cell death protein 1
PD-L1/PD-L2,	programmed cell death 1 ligand 1/2
PI3K,	phosphatidylinositol-4,5-bisphosphate 3-kinase
P2RY8,	P2Y purinoceptor 8
p70S6K,	ribosomal protein S6 kinase beta-1
RNA,	ribonucleic acid
SS,	Sezary syndrome
STAT,	signal transducer and activator of transcription
S1PR2,	Sphingosine-1-phosphate receptor 2
TCR,	T cell receptor
TLR,	Toll-like receptor
t(14;18)/t(8;14),	chromosomal translocation between chromosomes 14 and 18 and 8 and 14, respectively
UV,	ultraviolet
VEGFR,	vascular endothelial growth factor receptor
WHO-EORTC,	World Health Organization—European Organization for Research and Treatment of Cancer
90Y-I,	90 Y-ibritumomab tiuxetan